Tevogen closed at $5.31 on Nov 5, down 7.17%, 98.6% below its 52-week closing high. Volume of 1.9K shares was 0.19× its 20-day average (below normal).
Split-adjusted performance: -18.2% over one month, -29.0% over six months.
Short interest was 55.4K shares at the Oct 15 settlement (3.9% of float, 10.4 days to cover).
No reported quarters with price history yet.
Percentile among 139 companies (100 = best)
Industry medians: 6-month return −24.1%, revenue growth +8.5%, net margin −226.4%, P/E 21.4×.
| Company | Price | Today | 6M | Rev. growth | Net margin | P/E | Mkt cap | |
|---|---|---|---|---|---|---|---|---|
| TVGNTevogen | $5.31 | −7.17% | −29.0% | — | — | — | $89.0M | |
| NMRANeumora Therapeutics | $0.5111 | −9.70% | −73.7% | — | — | — | $96.0M | Compare |
| LENZLENZ Therapeutics | $3.08 | −10.98% | −68.3% | −72.9% | −915.2% | — | $96.8M | Compare |
| BDTXBlack Diamond Therapeutics | $1.69 | −11.05% | −37.9% | — | — | — | $97.1M | Compare |
| ATRAAtara Biotherapeutics | $7.92 | −5.44% | −20.3% | −96.4% | −767.3% | — | $79.4M | Compare |
| TNYATenaya Therapeutics | $0.3400 | −8.08% | −59.9% | — | −3909.3% | — | $77.5M | Compare |
| AVXLAnavex Life Sciences | $1.11 | −12.30% | −64.6% | — | — | — | $102.4M | Compare |
| OTLKOutlook Therapeutics | $0.4308 | −6.77% | +99.7% | −99.4% | −233554.9% | — | $104.9M | Compare |
| VYGRVoyager Therapeutics | $1.73 | −7.75% | −56.4% | −39.1% | −773.2% | — | $106.3M | Compare |
Tevogen Inc is a healthcare enterprise engaged in biotechnology, artificial intelligence and technology, and healthcare services. Its operations focus on the development of biotechnology products, AI- and technology-based healthcare solutions, and healthcare service initiatives.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
